Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
Hosted on MSN
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic
U.S.-listed shares of BioNTech SE ended Monday nearly 3.2% lower, weighed down by a weak full-year revenue projection even as the German drugmaker posted a quarterly earnings beat. Retail traders, ...
(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly ...
BioNTech won’t proceed with further development of its BNT111 cancer vaccine candidate in a specific late-stage refractory melanoma setting, a company spokesperson told Fierce Biotech. The decision to ...
Hosted on MSN
Pfizer and BioNTech’s New Vaccine Study: A Potential Game-Changer for COVID-19 Prevention
Pfizer Inc ((PFE)), Biontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
Nov 13 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Thursday it sold a part of its stake in German drugmaker BioNTech SE (22UAy.DE), opens new tab, more than five years after both firms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results